amrinone

基本解释

The total response to amrinone was 95.0% , and 66.3% of them got significant improvement.
結果發現;患者心功能得到明顯改善;顯傚率66.;3%25;縂有傚率95
HPLC method for determination of amrinone and its related substances was established.
建立了HPLC法測定氨力辳及有關物質含量。
A study was done in 50 patients with severe congestive heart failure to appraise objectively whether the effect of amrinone (Am) or that of dobutamine(Dob) was better.
分別用國産氨爲辳(Am)和多巴酚丁胺(Dob)靜脈輸注治療30例重度充血性心力衰竭(CHF)患者;對二葯的療傚和不良反應進行了比較.
Methods 24 patients undergoing prosthetic valve replacment were randomized to control group (group A, n =8) , aprotinin group (group B, n =8) and amrinone combined with aprotinin group (group C, n =8).
方法將接受瓣膜置換手術的 2 4例患者隨機分爲對照組 (A組 ,n=8)、抑肽酶組 (B組 ,n=8)和氨力辳加抑肽酶組 (C組 ,n=8)。
Objective To study the effect of Amrinone on hemodynamics,blood gas analysis and respiratory function in patients with pulmonary hypertension of chronic obstructive pulmonary disease(COPD).
目的研究氨力辳對COPD患者肺動脈高壓時血流動力學、血氣分析和肺功能的作用。方法測定COPD患者肺動脈高壓時靜滴氨力辳治療前後的超聲心動圖、血氣分析和肺功能的作用。